Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Hydrocarbon doai
Patent
1997-02-11
1998-05-12
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Hydrocarbon doai
514934, A01N 2700, A01N 3100, A61K 39245
Patent
active
057505780
ABSTRACT:
A therapeutic method is provided for treating a mammal afflicted with a herpesvirus infection comprising administering an effective amount of betulin or a derivative thereof.
REFERENCES:
Challand, R., et al., (eds.), "Herpes Viruses", Chapter 6, In: Antiviral Chemotherapy, Biochemical & Medicinal Chemistry Series, Spectrum & University Science Books, Sausalito, CA, pp. 54-67 (1996).
Arbesfeld, D.M., et al., "Cutaneous Herpes Simplex Virus Infections", Am. Family Physician, 43, 1655-1664, (1991).
Bean, B., "Acyclovir in the treatment of herpesvirus infections", Postgrad. Med., 73, 297-303, (1983).
Chatis, P.A., et al., "Analysis of the Thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex viruses", Virol., 180, 793-797, (1991).
Haase, A.T., "Methods in viral pathogenesis: tissues, organs and animals", Virol. Pathologenesis, N. Nathanson, ed., Lippincott-Raven publishers, Hagerstown, MD, 465-506, (1996).
Hayek, E.W., et al., "A bicentennial of betulin", Phytochemistry, 28, 2229-2242, (1989).
Konoshima, T., et al., "Studies on inhibitors of skin-tumor promotion, I. inhibitory effects of Triterpenes from Euptelea polyandra on epstein-barr virus activation", J. of Natural Products, 50, 1167-1170, (1987).
Pisha, E., et al., "Discovery of betulinic acid as a selective inhiibitor of human melanoma that functions by induction of apoptosis", Nature Med., 1, 1046-1051, (1995).
Roizman, B., et al., "An inquiry into the mechanisms of herpes simplex virus latency", Ann. Rev. of Microbiology, 41, 543-571, (1987).
Roizman, B., et al., "Herpes simplex viruses and their replication", Virol., Raven Press, NY (2nd ed.), 1795-1841, (1990).
Alarcon et al. Antiviral Research 4: 231-243, 1984.
Fujioka et al. CA 120: 289424v, J. Nat. Prod. 57(2): 243-247, 1994.
Platanov et al. CA 123: 334728x, Khim:-Farm Zh. 29(2): 42-46, 1995.
Tan et al. CA 117: 124048a, Biochem. Biophys. Res. Commun. 185(1): 370-378, 1992.
Alarcon et al. CA 102: 39536, Antiviral Research, 4(5): 231-244, 1984.
Carlson Robert M.
Karim M. Reza-Ul
Krasutsky Pavel A.
Kunz Gary L.
Regents of the University of Minnesota
LandOfFree
Use of betulin and analogs thereof to treat herpesvirus infectio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of betulin and analogs thereof to treat herpesvirus infectio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of betulin and analogs thereof to treat herpesvirus infectio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-979513